Liu Miaosen, Lv Jialan, Pan Zhicheng, Wang Dongfei, Zhao Liding, Guo Xiaogang
Clinical Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Front Cardiovasc Med. 2022 Aug 24;9:945142. doi: 10.3389/fcvm.2022.945142. eCollection 2022.
The ATP consumption in heart is very intensive to support muscle contraction and relaxation. Mitochondrion is the power plant of the cell. Mitochondrial dysfunction has long been believed as the primary mechanism responsible for the inability of energy generation and utilization in heart failure. In addition, emerging evidence has demonstrated that mitochondrial dysfunction also contributes to calcium dysregulation, oxidative stress, proteotoxic insults and cardiomyocyte death. These elements interact with each other to form a vicious circle in failing heart. The role of mitochondrial dysfunction in the pathogenesis of heart failure has attracted increasing attention. The complex signaling of mitochondrial quality control provides multiple targets for maintaining mitochondrial function. Design of therapeutic strategies targeting mitochondrial dysfunction holds promise for the prevention and treatment of heart failure.
心脏中的ATP消耗非常强烈,以支持肌肉收缩和舒张。线粒体是细胞的动力工厂。长期以来,线粒体功能障碍一直被认为是心力衰竭中能量产生和利用能力不足的主要机制。此外,新出现的证据表明,线粒体功能障碍还会导致钙调节异常、氧化应激、蛋白毒性损伤和心肌细胞死亡。这些因素相互作用,在衰竭的心脏中形成恶性循环。线粒体功能障碍在心力衰竭发病机制中的作用已引起越来越多的关注。线粒体质量控制的复杂信号为维持线粒体功能提供了多个靶点。针对线粒体功能障碍设计治疗策略有望预防和治疗心力衰竭。